好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Safety and Efficacy of Switching from Natalizumab to Dimethy Fumarate: Real World Experience
Multiple Sclerosis
(-)
289
Authors/Disclosures
Faria S. Amjad, MD (Medstar Georgetown University Hospital)
PRESENTER
Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. An immediate family member of Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myer Squibb. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Piramal.
No disclosure on file
Carlo S. Tornatore, MD (Medstar Georgetown University Hospital) Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Dana Horakova Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.